HighTower Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.7M | Buy |
155,318
+138,145
| +804% | +$14.3M | 0.02% | 738 |
|
|
2026
Q1 | $1.66M | Sell |
17,173
-65
| -0.4% | -$6.67K | ﹤0.01% | 1831 |
|
|
2025
Q4 | $1.83M | Buy |
17,238
+450
| +3% | +$52.2K | ﹤0.01% | 1720 |
|
|
2025
Q3 | $2.13M | Sell |
16,788
-2
| -0% | -$238 | ﹤0.01% | 1593 |
|
|
2025
Q2 | $2.06M | Sell |
16,790
-2,155
| -11% | -$246K | ﹤0.01% | 1546 |
|
|
2025
Q1 | $1.92M | Sell |
18,945
-10
| -0.1% | -$976 | ﹤0.01% | 1549 |
|
|
2024
Q4 | $1.75M | Buy |
18,955
+1,764
| +10% | +$173K | ﹤0.01% | 1604 |
|
|
2024
Q3 | $1.66M | Sell |
17,191
-1,160
| -6% | -$104K | ﹤0.01% | 1621 |
|
|
2024
Q2 | $1.59M | Buy |
18,351
+944
| +5% | +$79.2K | ﹤0.01% | 1576 |
|
|
2024
Q1 | $1.44M | Buy |
17,407
+943
| +6% | +$69.1K | ﹤0.01% | 1594 |
|
|
2023
Q4 | $1.1M | Buy |
16,464
+2,673
| +19% | +$173K | ﹤0.01% | 1797 |
|
|
2023
Q3 | $930K | Buy |
13,791
+2,983
| +28% | +$205K | ﹤0.01% | 1821 |
|
|
2023
Q2 | $740K | Buy |
10,808
+3,954
| +58% | +$248K | ﹤0.01% | 1934 |
|
|
2023
Q1 | $370K | Sell |
6,854
-286
| -4% | -$16.6K | ﹤0.01% | 2304 |
|
|
2022
Q4 | $436K | Buy |
+7,140
| New | +$388K | ﹤0.01% | 2210 |
|
|
2022
Q3 | – | Sell |
-4,745
| Closed | -$212K | – | 3212 |
|
|
2022
Q2 | $212K | Buy |
4,745
+352
| +8% | +$18.1K | ﹤0.01% | 2600 |
|
|
2022
Q1 | $248K | Buy |
4,393
+161
| +4% | +$8.41K | ﹤0.01% | 2667 |
|
|
2021
Q4 | $220K | Sell |
4,232
-616
| -13% | -$31.8K | ﹤0.01% | 2689 |
|
|
2021
Q3 | $290K | Buy |
4,848
+760
| +19% | +$47.8K | ﹤0.01% | 2430 |
|
|
2021
Q2 | $253K | Sell |
4,088
-242
| -6% | -$16.1K | ﹤0.01% | 2489 |
|
|
2021
Q1 | $282K | Sell |
4,330
-165
| -4% | -$10.8K | ﹤0.01% | 2346 |
|
|
2020
Q4 | $294K | Buy |
+4,495
| New | +$264K | ﹤0.01% | 1943 |
|
|
2020
Q2 | – | Sell |
-4,131
| Closed | -$210K | – | 2454 |
|
|
2020
Q1 | $210K | Buy |
4,131
+471
| +13% | +$27.2K | ﹤0.01% | 1762 |
|
|
2019
Q4 | $201K | Buy |
+3,660
| New | +$199K | ﹤0.01% | 1973 |
|
|
2019
Q2 | – | Sell |
-9,401
| Closed | -$439K | – | 2417 |
|
|
2019
Q1 | $439K | Buy |
9,401
+569
| +6% | +$28.8K | ﹤0.01% | 1527 |
|
|
2018
Q4 | $431K | Buy |
8,832
+1,228
| +16% | +$69.8K | ﹤0.01% | 1432 |
|
|
2018
Q3 | $469K | Buy |
+7,604
| New | +$462K | ﹤0.01% | 1489 |
|
Other funds holding EHC
HighTower Advisors's EHC Position: Q2 2026 in Review
HighTower Advisors increased its Encompass Health (EHC) stake by 804% in Q2 2026, buying an estimated $14.3M and bringing the position to 155,318 shares worth $15.7M. The position accounts for 0.02% of the portfolio, ranked #738.
HighTower Advisors first reported a position in EHC in Q3 2018 and has held it in 27 quarters since. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- HighTower Advisors held 155,318 shares of Encompass Health worth $15.7M as of Q2 2026.
- HighTower Advisors bought 138,145 Encompass Health shares in Q2 2026, an estimated $14.3M.
- Encompass Health made up 0.02% of HighTower Advisors's portfolio in Q2 2026, its #738 holding.
- HighTower Advisors first reported a position in Encompass Health in Q3 2018 and has held it in 27 quarters since.
- 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.